Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maintenance Ketamine Infusions for Treatment-Resistant Bipolar Depression
NCT05339074Phase 2Completed
- Start
- Aug 2022
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ketamine in bipolar disorder (BD). Started Aug 2022; status: completed.
02
Drugs
ketamine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT05339074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05339074.